Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Solary

Showing results (211-220 of 273) with videos related to

Pageof 28
Sort By:
Oncoimmunology|September 17, 2020
Immune responses during COVID-19 infectionCléa Melenotte, Aymeric Silvin, Anne-Gaëlle Goubet, et al.
Blood|December 14, 2011
Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromesEmilie Frisan, Julie Vandekerckhove, Aurélie de Thonel, et al.
Blood|July 8, 2011
Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitorsElodie Pronier, Carole Almire, Hayat Mokrani, et al.
The Journal of Clinical Investigation|January 23, 2010
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsFanny Chalmin, Sylvain Ladoire, Grégoire Mignot, et al.
Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Autoimmunity Reviews|December 16, 2019
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature reviewAnne Laure Roupie, Hubert de Boysson, Sara Thietart, et al.
Blood|August 12, 2009
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, et al.
Haematologica|July 23, 2013
STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation modelLucile Couronné, Laurianne Scourzic, Camilla Pilati, et al.
Cell Chemical Biology|February 27, 2018
MUB<sub>40</sub> Binds to Lactoferrin and Stands as a Specific Neutrophil MarkerMark C Anderson, Thibault Chaze, Yves-Marie Coïc, et al.
Pageof 28

Showing results (211-220 of 273) with videos related to

Sort By:
Pageof 28
Oncoimmunology|September 17, 2020
Immune responses during COVID-19 infectionCléa Melenotte, Aymeric Silvin, Anne-Gaëlle Goubet, et al.
Blood|December 14, 2011
Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromesEmilie Frisan, Julie Vandekerckhove, Aurélie de Thonel, et al.
Blood|July 8, 2011
Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitorsElodie Pronier, Carole Almire, Hayat Mokrani, et al.
The Journal of Clinical Investigation|January 23, 2010
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsFanny Chalmin, Sylvain Ladoire, Grégoire Mignot, et al.
Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Autoimmunity Reviews|December 16, 2019
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature reviewAnne Laure Roupie, Hubert de Boysson, Sara Thietart, et al.
Blood|August 12, 2009
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, et al.
Haematologica|July 23, 2013
STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation modelLucile Couronné, Laurianne Scourzic, Camilla Pilati, et al.
Cell Chemical Biology|February 27, 2018
MUB<sub>40</sub> Binds to Lactoferrin and Stands as a Specific Neutrophil MarkerMark C Anderson, Thibault Chaze, Yves-Marie Coïc, et al.
Pageof 28